Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

9.71
Delayed Data
As of Jun 30
 -0.17 / -1.72%
Today’s Change
7.36
Today|||52-Week Range
16.68
-17.50%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Kiniksa Pharmaceuticals Ltd have a median target of 22.00, with a high estimate of 28.00 and a low estimate of 16.00. The median estimate represents a +126.57% increase from the last price of 9.71.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Kiniksa Pharmaceuticals Ltd. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.43
Sales
$28.4M
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.06%
 
 
 
 
 
 
Growthannually 34.89%
 
 
 
 
 
 

Sales

Growthquarterly -11.71%
 
 
 
 
 
 
Growthannually 240.22%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.